Ahab is my ID there Tonoos, I'm sure you've seen me there. I too agree with what you are saying about GTHP for they are lining up all the ducks in a row and doing the right things to be a major player in their diagnostics field. Rome was not built in a day & neither will GTHP.
100 shares at .064. $6.40. Golly miss molly, the commission to trade it is more than the 100 shares that were bought or it's someone that is on a margin call and is trying to get the highest price at the ask but it's way too early. Worry about that at 3:55, right b4 the close
Wolf, it sure has great future possibilities here. I too like the news on the Q today even though revenue was down but was expected and their day to day operations costs are down which also was expected. I like the down the road business that GC is generating with Indonesia & China. Those two alone with purchases of machines and disposables look very good but again, this is down the road but not to be forgotten for that is GTHP's great future. Lastly, FDA approval if and when that comes will always be a +++ but politics are getting in the way and palms are open within our government to accept big pharma's payments to keep Luviva from getting approved for big pharma doesn't want Luviva to exist and that is JMHO of course - GLTU
Here's a link on Yahoo since can't post long messages - GLTA
Hey Kar, whazup? Nice to see U here still. I too am still long here with a few other stocks INCLUDING ARTH, are you still invested there? I, after a long time got back into it around .254 and rode it up and down but it sure looks good for the future. Hey, best to you Kar
Welcome back Ed, nice to see you posting here. I got back in just recently and am waiting for things to happen. Again, good to see you posting here and ignore the rest of the noise. Someday, I hope GTHP get's noticed for what it can do for health - GLTU
Sorry folks, forgot the link from CNBC on Black Rock and it's 1% not 3.4% but it is $217,727.00
I don't know if anyone noticed but Black Rock bought in recently with about 217,000 dollars or 3.4% I think, but they did recently invest in ONCS
wrong bud, he bought 5K direct and the rest were options. About 27K plus in dollars, give us a break
I wish everyone good luck Jham and I put this in the wrong place. I was referring to another comment you posted up higher:
"jhamreturns • Jul 1, 2015 9:40 AM
I didn't say it was a big deal. I know starting a trial is a big task and depends on many moving parts coming together. That said, it shouldn't take 7 months and they shouldn't have to pushback the timeline twice. If missing previous guidance by 90 days isn't a big deal, then where do you draw the line? 120 days? 300? If investors can't trust guidance by management that is not good.
The above said, it is not the end of the world, but if they have only begun screening patients (not saying that is the case), it could take a few more weeks until the first patient is enrolled. Hopefully they are further along than that and have some news for us on this front just before or around the time of the Nasdaq bell ringing. Less
Don't forget the patent ofc did approve ONCS's OWN device to use I believe, (correct me if I'm wrong) but that could have been another reasons why the trial has taken longer than promised, eh? Oncosec wouldn't have to share revenues with INO if they waited for that patent, just saying - GLTU Jham
copphiggins, now that is exactly what I think is going to happen. The 7th of July is when ONCS will announce the trial was approved and they might even add that they are starting to enroll on that same day. They'll do it with a splash - GLTU
Hey Tonoos, how are you? Hey, I agree, that's why I am saying forward progress so far internationally is what is driving sales & revenue. I don't disagree but on the other hand, I am also saying that it would be nice to have USA FDA approval down the line some time, that's all - GLTU